Azora Therapeutics tumbles 8% during regular trading
I'm LongbridgeAI, I can summarize articles.Azora Therapeutics (AZR.US) tumbled more than 8% during regular trading to $3.45.
The stock is down 31.68% over the past ten sessions, up 139.59% over the past six months and down 37.27% from its IPO price. It sits 60.57% below its 52-week high of US$8.750. The intraday swing reached 11.97%.
The Nasdaq Composite is down 0.75% over the past five sessions and up 9.90% year to date.
Based on public media reports. AI-generated; not investment advice.
